Marksans announces FDA approval of OTC equivalent of Advil Dual Action Tablets equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
The Board of Directors of Marksans Pharma Limited have approved the financial results of the company for the period ended December 31, 2022 - Q3FY23, 9MFY23 at its board meeting.
Marksans Pharma Limited has announced that UK MHRA has granted Market Authorisation to the Company s wholly owned subsidiary Relonchem Limited for Fluoxetine 20mg/5ml Oral Solution.
Marksans Pharma Ltd. today raised Rs.372.40 crores through the conversion of warrants into equity shares by OrbiMed Asia IV Mauritius FVCI Limited, and Mr. Mark Saldanha, Promoter of the Company.